The Globe and Mail reports in its Wednesday, Nov. 1, edition that Raymond James analyst Stephen Boland aggressively cut his share target on Dye & Durham but is still recommending the stock, which fell to all-time lows last week. The Globe's Darcy Keith writes in the Eye On Equities column that Mr. Boland is sticking with his "outperform" recommendation while slashing his price target to $15 from $25. Analysts on average target the shares at $22.86, down from $26.14 a month ago. Dye & Durham reported first quarter results on Monday, with revenue of $120.1-million above consensus. Concerns, however, remain over leverage, and the company has announced a number of initiatives to help reduce debt. Mr. Boland says in a note, "It may take time for the shares to fully recover as investors wait for evidence that management's plan is taking hold." The Globe reported on Feb. 15 that BMO rated Dye & Durham "outperform." It was then worth $20.63. The Globe reported on Sept. 15 that CIBC had reaffirmed its "outperformer" call on Dye & Durham when it was worth $16.45.